StonvexLoading…
StonvexStonvexStonvexCore line items from TRN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2025 2025-09-30 | Annual 2025 2025-06-30 | Annual 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $2.16B | $454.10M | $506.20M | $585.40M |
Operating Income | $649.20M | $118.60M | $95.40M | $99.80M |
Net Income | $253.10M | $30.30M | $14.10M | $22.10M |
EPS (Diluted) | $3.05 | $0.37 | $0.17 | $0.26 |
Total Assets | $8.42B | Not available | Not available | Not available |
Total Liabilities | $7.28B | Not available | Not available | Not available |
Cash & Equivalents | $201.30M | Not available | Not available | Not available |
Free Cash Flow OCF − CapEx | $314.10M | Not available | Not available | Not available |
Shares Outstanding | 82.90M | Not available | Not available | Not available |